| |
| |
|
|
| |
ESDaP – Sister Society of EADV is looking
forward to an ever increasing role within the future of EADV |
|
The
European Society for Dermatology and Psychiatry (ESDaP) - a sister society
of the EADV since 1983 - is looking back at almost a quarter of a century
of clinical experience and scientific research in the field of
psychodermatology. Since the foundation of a ESDaP an increasing number of
articles in scientific journals and several books have appeared which
document the paramount importance of taking into account the impact of
psychological problems and the need of their management in dermatology and
venerology: recent epidemiological studies have for showed instance that
25-30% of all dermatological patients have severe psychological problems
which have to be treated additionally.
ESDaP has been actively participating to all annual EADV congresses;
moreover, it organizes its own congress with broad international (European
and overseas) participation every two years. The last congress took place
at the University of Giessen/Germany, a research a clinical center where
psychodermatology has always been given high consideration. The 2005
congress has given a chance to dermatologists, psychiatrists,
psychologists, nurses as well as other people working in the field of
psychodermatology to meet and exchange their ideas and set up new projects.
The next ESDaP congress will take place from June 14th until June 17th,
2006 in Wroclaw (Poland). This witnesses the increasing interest of our
Eastern European colleagues in psychodermatology.
Guidelines for psychodermatology are beeing established by different teams:
The German Working Group, the Belgo-Italian psychosomatic research group
and the French society for psychosomatic dermatology.
They reflect the fact that psychodermatology is not confined to ‘classical
psychodermatological subjects” such as delusion of parasitosis or
factitious disorders, but concerns also other, more general aspects of
dermatology such as diagnosis (for instance in as far as
countertransference is concerned) and other faces of the doctor/patient
relationship, optimisation of treatment, compliance and other aspects of
the whole discipline for all dermatological patients.
Public Health Issues such as quality of life or patients’ education are
likewise closely connected with our subdiscipline – as reflected by the
impact of the recent psychotherapeutical or educational programs developed
for patients patients affected by atopic dermatitis, psoriasis, chronic
urticaria or acne..(similar projects for other dermatological diseases are
currently being developed)
But also basic science is connected with psychodermatology, as shown by
the results achieved during the last decades in psychoneuroimmunological
research. Increased knowledge about psychoimmunological and
psychoendocrine pathways shows evidence of mechanisms of influence from
stress, depression or other psychological factors on skin diseases..
Depression, anxiety and other affective disorders are a common concern for
physicians dealing with dermatological patients. Diagnostic tools need to
be further refined, and optimisation of therapeutical strategies,
combining psychotherapeutical, social and pharmacological interventions,
is needed to achieve a maximum benefit for the patients. The practical and
theoretical contribution of psychodermatology in this respect is
irreplaceable.
An ever increasing rate of patients (presently about as many as 10% of the
total number) seeking advice from cosmetic dermatologists or plastic
surgeons is actually affected – to a greater of less extent – by some sort
of body dismorphic disorder (BDD). This accounts for the paramount
importance of this disease, where much research – especially concerning
epidemiological aspects - has been completed but where more is still
needed.
Likewise, patients seeking advice from dermatologists not uncommonly
present also with signs of factitious disorders, obsessive-compulsive
disorders, hypochondria, social phobia or/and anxiety,
It is hence understandable that we are obtaining increasing evidence of
the efficacy of psychotherapeutic interventions (psychodynamic therapies,
behaviour therapy, psychotherapy with psychoanalytical orientation, family
systemic therapy, Relaxation training, body work etc. with dermatological
patients. Also psychotropic drugs are more and more used in dermatology -
thus requiring dermatologists to achieve special skills and knowledges in
this field – since these drugs may need to be offered to ‘difficult’
patients who may show an important psychological (co)etiology of the
complaints but may at the same time be reluctant or totally unwilling to
be referred to a psychiatrist.
The president of the ESDaP is Prof. Dr. Michael Musalek (psychiatrist,
Vienna), who founded the society in 1983 together with Dr. John Cotterill,
(consultant dermatologist, Leeds) and Prof. Peter Berner (psychiatrist,
Vienna). President elect is Dr. Sylvie Consoli (dermatologist,
psychiatrist and psychoanalyst, Paris) and the secretary is Dr. Francoise
Poot (dermatologist, psychotherapist, Brussels)
In most European countries scientific societies, work groups or groups of
interest for psychodermatology have come into being, although in some
countries, only a few – sometimes one or two - dermatologists are
interested in psychocutaneous issues. As it is the case for the
dermatological national societies and the EADV board, representatives of
psychodermatological national societies and work groups from most European
countries are present in the ESDaP steering committee.
ESDaP is organizing a summer course in psychodermatology in 2007 in
Brussels with the help and funding of the EADV – this is to be seen within
the EADV fostering program for dermatology trainees from all European
countries.
ESDaP is hence a well recognized sister society of EADV, ESDaP symposiums
are always filled up with interested dermatologist from all over the world
.
ESDaP is the largest society in the world dealing with psychocutaneous
issues, and is in touch with other, similar Societies : Association of
Psychocutaneous Medicine of North American, US and Osaka Psychodermatology
Research Group,Japan.
|
|